AxoGen, Inc. (0HKD.L)
USD 16.93
(0.5%)
USD 16.93
(0.5%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 32.26 Million USD | -38.12% |
| 2022 | 52.14 Million USD | 50.28% |
| 2021 | 34.69 Million USD | 594.36% |
| 2020 | 4.99 Million USD | 115.43% |
| 2019 | -32.39 Million USD | -33.68% |
| 2018 | -24.23 Million USD | -104.2% |
| 2017 | -11.86 Million USD | -108.08% |
| 2016 | -5.7 Million USD | -1474.99% |
| 2015 | -362.08 Thousand USD | -102.15% |
| 2014 | 16.86 Million USD | 218.67% |
| 2013 | 5.29 Million USD | -31.0% |
| 2012 | 7.67 Million USD | 328.88% |
| 2011 | -3.35 Million USD | -353.35% |
| 2010 | 1.32 Million USD | 108.39% |
| 2009 | -15.76 Million USD | -4636.73% |
| 2008 | -332.84 Thousand USD | 60.04% |
| 2007 | -832.92 Thousand USD | 35.02% |
| 2006 | -1.28 Million USD | 2.2% |
| 2005 | -1.31 Million USD | 41.41% |
| 2004 | -2.23 Million USD | -1084.48% |
| 2003 | -188.84 Thousand USD | -138.26% |
| 2002 | 493.58 Thousand USD | 236.64% |
| 2001 | -361.23 Thousand USD | -145.66% |
| 2000 | 791.11 Thousand USD | 179.11% |
| 1999 | -1 Million USD | 54.55% |
| 1998 | -2.2 Million USD | -214.29% |
| 1997 | -700 Thousand USD | 12.5% |
| 1996 | -800 Thousand USD | 0.0% |
| 1995 | -800 Thousand USD | 0.0% |
| 1994 | -800 Thousand USD | -100.0% |
| 1993 | -400 Thousand USD | 73.33% |
| 1992 | -1.5 Million USD | -200.0% |
| 1991 | -500 Thousand USD | -350.0% |
| 1990 | 200 Thousand USD | 100.0% |
| 1989 | 100 Thousand USD | 133.33% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 43.84 Million USD | -7.58% |
| 2024 Q1 | 47.43 Million USD | 47.02% |
| 2023 Q3 | 36.3 Million USD | -17.68% |
| 2023 FY | 32.26 Million USD | -38.12% |
| 2023 Q1 | 59.36 Million USD | 13.85% |
| 2023 Q2 | 44.1 Million USD | -25.7% |
| 2023 Q4 | 32.26 Million USD | -11.13% |
| 2022 FY | 52.14 Million USD | 50.28% |
| 2022 Q1 | 53.43 Million USD | 54.0% |
| 2022 Q2 | 55.85 Million USD | 4.54% |
| 2022 Q3 | 53.33 Million USD | -4.52% |
| 2022 Q4 | 52.14 Million USD | -2.23% |
| 2021 FY | 34.69 Million USD | 594.36% |
| 2021 Q1 | 14.47 Million USD | 189.57% |
| 2021 Q3 | 22.45 Million USD | 48.34% |
| 2021 Q4 | 34.69 Million USD | 54.53% |
| 2021 Q2 | 15.13 Million USD | 4.6% |
| 2020 FY | 4.99 Million USD | 115.43% |
| 2020 Q4 | 4.99 Million USD | 174.47% |
| 2020 Q1 | -32.92 Million USD | -1.63% |
| 2020 Q2 | -41.8 Million USD | -27.0% |
| 2020 Q3 | -6.71 Million USD | 83.95% |
| 2019 FY | -32.39 Million USD | -33.68% |
| 2019 Q3 | -20.78 Million USD | -0.56% |
| 2019 Q2 | -20.66 Million USD | -9.12% |
| 2019 Q1 | -18.93 Million USD | 21.84% |
| 2019 Q4 | -32.39 Million USD | -55.89% |
| 2018 Q1 | -5.97 Million USD | 49.65% |
| 2018 Q4 | -24.23 Million USD | 5.18% |
| 2018 FY | -24.23 Million USD | -104.2% |
| 2018 Q2 | -133.47 Million USD | -2134.16% |
| 2018 Q3 | -25.55 Million USD | 80.85% |
| 2017 Q3 | 2.33 Million USD | 682.28% |
| 2017 Q2 | 298.76 Thousand USD | 118.24% |
| 2017 Q4 | -11.86 Million USD | -607.72% |
| 2017 FY | -11.86 Million USD | -108.08% |
| 2017 Q1 | -1.63 Million USD | 71.28% |
| 2016 Q2 | 6.67 Million USD | 73.22% |
| 2016 FY | -5.7 Million USD | -1474.99% |
| 2016 Q3 | 8.99 Million USD | 34.64% |
| 2016 Q4 | -5.7 Million USD | -163.41% |
| 2016 Q1 | 3.85 Million USD | 1164.88% |
| 2015 Q4 | -362.08 Thousand USD | 91.77% |
| 2015 Q2 | 9.8 Million USD | 63.03% |
| 2015 Q1 | 6.01 Million USD | -64.35% |
| 2015 FY | -362.08 Thousand USD | -102.15% |
| 2015 Q3 | -4.39 Million USD | -144.86% |
| 2014 Q4 | 16.86 Million USD | 3.05% |
| 2014 FY | 16.86 Million USD | 218.67% |
| 2014 Q1 | 9.44 Million USD | 78.46% |
| 2014 Q2 | 13.07 Million USD | 38.36% |
| 2014 Q3 | 16.37 Million USD | 25.24% |
| 2013 Q4 | 5.29 Million USD | 203.19% |
| 2013 Q3 | 1.74 Million USD | -88.11% |
| 2013 FY | 5.29 Million USD | -31.0% |
| 2013 Q1 | 11.23 Million USD | 46.46% |
| 2013 Q2 | 14.69 Million USD | 30.73% |
| 2012 Q2 | 224.18 Thousand USD | 128.33% |
| 2012 Q1 | -791.23 Thousand USD | 76.4% |
| 2012 FY | 7.67 Million USD | 328.88% |
| 2012 Q4 | 7.67 Million USD | 251.94% |
| 2012 Q3 | 2.18 Million USD | 872.49% |
| 2011 Q2 | -9.55 Million USD | -69.38% |
| 2011 Q1 | -5.64 Million USD | -526.34% |
| 2011 Q3 | -5.69 Million USD | 40.35% |
| 2011 Q4 | -3.35 Million USD | 41.18% |
| 2011 FY | -3.35 Million USD | -353.35% |
| 2010 Q3 | -9.28 Million USD | 3.64% |
| 2010 FY | 1.32 Million USD | 108.39% |
| 2010 Q4 | 1.32 Million USD | 114.25% |
| 2010 Q2 | -9.63 Million USD | 5.36% |
| 2010 Q1 | -10.17 Million USD | 35.43% |
| 2009 FY | -15.76 Million USD | -4636.73% |
| 2009 Q4 | -15.76 Million USD | -6830.71% |
| 2009 Q2 | -211.23 Thousand USD | 12.81% |
| 2009 Q1 | -242.25 Thousand USD | 27.22% |
| 2009 Q3 | -227.48 Thousand USD | -7.69% |
| 2008 Q4 | -332.84 Thousand USD | 18.84% |
| 2008 Q2 | -588.6 Thousand USD | 27.23% |
| 2008 Q3 | -410.1 Thousand USD | 30.33% |
| 2008 Q1 | -808.87 Thousand USD | 2.89% |
| 2008 FY | -332.84 Thousand USD | 60.04% |
| 2007 Q3 | -943.39 Thousand USD | 10.48% |
| 2007 Q1 | -1.22 Million USD | 4.17% |
| 2007 FY | -832.92 Thousand USD | 35.02% |
| 2007 Q4 | -832.92 Thousand USD | 11.71% |
| 2007 Q2 | -1.05 Million USD | 14.21% |
| 2006 FY | -1.28 Million USD | 2.2% |
| 2006 Q2 | -1.44 Million USD | -1.06% |
| 2006 Q3 | -1.36 Million USD | 5.8% |
| 2006 Q4 | -1.28 Million USD | 5.88% |
| 2006 Q1 | -1.43 Million USD | -9.15% |
| 2005 Q4 | -1.31 Million USD | 3.26% |
| 2005 FY | -1.31 Million USD | 41.41% |
| 2005 Q3 | -1.35 Million USD | 8.31% |
| 2005 Q2 | -1.47 Million USD | 4.69% |
| 2005 Q1 | -1.55 Million USD | 30.69% |
| 2004 Q1 | -441.23 Thousand USD | -133.65% |
| 2004 Q2 | -602.54 Thousand USD | -36.56% |
| 2004 Q3 | -2.11 Million USD | -250.22% |
| 2004 Q4 | -2.23 Million USD | -6.0% |
| 2004 FY | -2.23 Million USD | -1084.48% |
| 2003 Q1 | -82.89 Thousand USD | -116.79% |
| 2003 Q3 | -43.07 Thousand USD | 66.29% |
| 2003 Q4 | -188.84 Thousand USD | -338.38% |
| 2003 FY | -188.84 Thousand USD | -138.26% |
| 2003 Q2 | -127.78 Thousand USD | -54.15% |
| 2002 Q3 | 658.74 Thousand USD | 18.91% |
| 2002 Q1 | 645.42 Thousand USD | 0.0% |
| 2002 FY | 493.58 Thousand USD | 236.64% |
| 2002 Q2 | 554 Thousand USD | -14.17% |
| 2002 Q4 | 493.58 Thousand USD | -25.07% |
| 2001 Q3 | -1.05 Million USD | 57.36% |
| 2001 Q2 | -2.47 Million USD | -299.2% |
| 2001 Q1 | 1.24 Million USD | 35.18% |
| 2001 FY | -361.23 Thousand USD | -145.66% |
| 2000 Q1 | 376.5 Thousand USD | 0.0% |
| 2000 Q2 | 791.11 Thousand USD | 110.12% |
| 2000 Q3 | 686.68 Thousand USD | -13.2% |
| 2000 Q4 | 920.54 Thousand USD | 34.06% |
| 2000 FY | 791.11 Thousand USD | 179.11% |
| 1999 Q4 | - USD | 100.0% |
| 1999 Q2 | -1 Million USD | -11.11% |
| 1999 Q1 | -900 Thousand USD | 10.0% |
| 1999 FY | -1 Million USD | 54.55% |
| 1999 Q3 | -500 Thousand USD | 50.0% |
| 1998 Q4 | -1 Million USD | 50.0% |
| 1998 FY | -2.2 Million USD | -214.29% |
| 1998 Q1 | -1.6 Million USD | 0.0% |
| 1998 Q2 | -2.2 Million USD | -37.5% |
| 1998 Q3 | -2 Million USD | 9.09% |
| 1997 Q3 | -600 Thousand USD | 14.29% |
| 1997 Q2 | -700 Thousand USD | -40.0% |
| 1997 Q1 | -500 Thousand USD | 16.67% |
| 1997 FY | -700 Thousand USD | 12.5% |
| 1997 Q4 | -1.6 Million USD | -166.67% |
| 1996 Q1 | -100 Thousand USD | 75.0% |
| 1996 Q2 | -800 Thousand USD | -700.0% |
| 1996 Q3 | -400 Thousand USD | 50.0% |
| 1996 FY | -800 Thousand USD | 0.0% |
| 1996 Q4 | -600 Thousand USD | -50.0% |
| 1995 Q1 | -700 Thousand USD | 12.5% |
| 1995 Q4 | -400 Thousand USD | -33.33% |
| 1995 FY | -800 Thousand USD | 0.0% |
| 1995 Q3 | -300 Thousand USD | 62.5% |
| 1995 Q2 | -800 Thousand USD | -14.29% |
| 1994 Q3 | -400 Thousand USD | 50.0% |
| 1994 FY | -800 Thousand USD | -100.0% |
| 1994 Q1 | -400 Thousand USD | -300.0% |
| 1994 Q2 | -800 Thousand USD | -100.0% |
| 1994 Q4 | -800 Thousand USD | -100.0% |
| 1993 Q4 | -100 Thousand USD | 75.0% |
| 1993 Q1 | -800 Thousand USD | -300.0% |
| 1993 FY | -400 Thousand USD | 73.33% |
| 1993 Q3 | -400 Thousand USD | 0.0% |
| 1993 Q2 | -400 Thousand USD | 50.0% |
| 1992 Q1 | -600 Thousand USD | -500.0% |
| 1992 Q4 | -200 Thousand USD | 50.0% |
| 1992 Q2 | -1.5 Million USD | -150.0% |
| 1992 Q3 | -400 Thousand USD | 73.33% |
| 1992 FY | -1.5 Million USD | -200.0% |
| 1991 Q3 | -300 Thousand USD | 40.0% |
| 1991 Q4 | -100 Thousand USD | 66.67% |
| 1991 Q2 | -500 Thousand USD | -266.67% |
| 1991 Q1 | 300 Thousand USD | 50.0% |
| 1991 FY | -500 Thousand USD | -350.0% |
| 1990 Q3 | - USD | -100.0% |
| 1990 Q4 | 200 Thousand USD | 0.0% |
| 1990 FY | 200 Thousand USD | 100.0% |
| 1990 Q2 | 200 Thousand USD | -99.57% |
| 1990 Q1 | 46 Million USD | 0.22% |
| 1989 Q4 | 45.9 Million USD | 11375.0% |
| 1989 Q3 | 400 Thousand USD | 300.0% |
| 1989 Q2 | 100 Thousand USD | 0.0% |
| 1989 FY | 100 Thousand USD | 133.33% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 142.715% |
| Accuray Incorporated | 103.58 Million USD | 68.851% |
| Align Technology, Inc. | -840.47 Million USD | 103.839% |
| Elevance Health Inc. | 18.59 Billion USD | 99.826% |
| Boston Scientific Corporation | 8.23 Billion USD | 99.608% |
| CVS Health Corporation | 71.18 Billion USD | 99.955% |
| Cardinal Health, Inc. | 476 Million USD | 93.221% |
| Centene Corporation | 506 Million USD | 93.623% |
| DaVita Inc. | 10.65 Billion USD | 99.697% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 99.921% |
| Hologic, Inc. | 374.4 Million USD | 91.382% |
| Humana Inc. | 5.51 Billion USD | 99.415% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 93.468% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 99.404% |
| Masimo Corporation | 804 Million USD | 95.987% |
| McKesson Corporation | 889 Million USD | 96.371% |
| Patterson Companies, Inc. | 648.47 Million USD | 95.024% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 99.311% |
| ResMed Inc. | 635.57 Million USD | 94.923% |
| Henry Schein, Inc. | 2.57 Billion USD | 98.745% |
| Teladoc Health, Inc. | 468.6 Million USD | 93.114% |
| Universal Health Services, Inc. | 5.24 Billion USD | 99.385% |
| Veeva Systems Inc. | -647.71 Million USD | 104.982% |
| Baxter International Inc. | 11.16 Billion USD | 99.711% |
| Becton, Dickinson and Company | 14.46 Billion USD | 99.777% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 101.213% |
| Danaher Corporation | 13.49 Billion USD | 99.761% |
| Stryker Corporation | 10.02 Billion USD | 99.678% |
| Medtronic plc | 23.67 Billion USD | 99.864% |